Bay Street News, June, 2020

SALT LAKE CITY, June 04, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global […]

NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]

NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene […]

SOUTH SAN FRANCISCO, Calif., June 04, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused […]

LONDON and REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) today […]

NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that its investment arm, Nasdaq Ventures, has taken […]

CRANBURY, N.J., June 04, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and […]

CANTON, Mass., June 04, 2020 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the largest omni-channel specialty retailer of […]

WALTHAM, Mass., June 04, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company pioneering targeted C3 therapies, […]

TORONTO, June 04, 2020 (GLOBE NEWSWIRE) — O3 Mining Inc. (TSX.V:OIII) (“O3 Mining” or the “Corporation”) is pleased to announce […]